Product Description
| Species | Dogs, cats, horses. | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Composition |
Medetomidine hydrochloride 1.0 mg/ml, additives up to 1 ml.
|
||||||||||||||||||||||||||||||||||
| Indications |
Meditin is used in dogs, cats, sports horses, wild and zoo animals for sedation, muscle relaxation, and analgesia during clinical and diagnostic examinations, chemical immobilization and to prevent aggression, as well as during surgical interventions for sedation and combined neuroleptanalgesia. |
||||||||||||||||||||||||||||||||||
| Dosage and method of administration | Meditin is administered parenterally: to dogs and cats intravenously, intramuscularly or subcutaneously; IV. to sport horses. If necessary, the drug can be re-administered 10-15 minutes after the first injection. To achieve sedative and analgesic effects, horses use Meditin 1% at a dose of 0.02-0.12 ml / 100 kg of body weight, dogs – Meditin 0.1% at a dose of 0.1-0.8 ml / 10 kg body weight, cats – Meditin 0.1% at a dose of 0.01 – 0.15 ml / kg of animal weight. Doses of the drug vary depending on the desired effect, individual characteristics and breed of animal. Small breed dogs require a higher dose of Meditin 0.1% than large breed dogs. For horses, the drug is administered intravenously slowly (1 ml per minute). It is recommended to use 2 sterile needles: one for filling the syringe, the other directly for injection. As soon as the required dose of the drug is drawn into the syringe, it is disconnected from the needle in the vial. An injection needle is inserted into the animal, and then the syringe with the drug is connected to it. Feeding of animals should be stopped 12 hours before using Meditin. During and after anesthesia, the animals should be kept warm.
Meditin is usually administered once. If it is necessary to reuse, the drug is administered 10-15 minutes after the first injection.
|
||||||||||||||||||||||||||||||||||
| Contraindications | It is forbidden to use the drug in animals with increased individual sensitivity to the components of the drug, severe cardiovascular diseases and diseases of the respiratory system, impaired liver or kidney function, damage to the gastrointestinal tract (volvulus of the stomach, entrapment of organs, obstruction of the esophagus), with diabetes mellitus, increased intraocular pressure. The drug should not be used in emaciated, weakened or shocked animals. | ||||||||||||||||||||||||||||||||||
| Warning |
|
||||||||||||||||||||||||||||||||||
| Release form | Meditin is produced 0.1% packaged in 5, 10, 20 ml in dark glass vials, sealed with rubber stoppers with aluminum caps. Meditin 1% is produced in packs of 5, 10, 20, 50 and 100 ml in dark glass bottles, sealed with rubber stoppers with aluminum caps. Vials are packed individually in cardboard boxes, complete with instructions for use. |
||||||||||||||||||||||||||||||||||
| Storage conditions | Store in the closed packaging of the manufacturer, protected from direct sunlight, separate from food and feed, at T (0 + 25 C). | ||||||||||||||||||||||||||||||||||
| Shelf life | 3 years from the date of production, after opening the bottle – 30 days. |
Meditin